FEATURES OF IMMUNE RESPONSE DURING VARIOUS SCHEMES OF USE OF BACTERIAL THERAPEUTIC VACCINE IMMUNOVAC VP-4

FEATURES OF IMMUNE RESPONSE DURING VARIOUS SCHEMES OF USE OF BACTERIAL THERAPEUTIC VACCINE IMMUNOVAC VP-4

Aim. Study the dynamics of immunologic parameters in patients with chronic bacterial infections during various schemes of administration of Immunovac VP-4 vaccine. Materials and methods. Parameters of systemic immunity and levels of specific antibodies of various isotypes in blood sera and saliva ag...

Full description

Bibliographic Details
Main Authors:	L. I. Krasnoproshina, T. A. Serova, E. P. Foshina, I. V. Bisheva, S. A. Skhodova
Format:	Article
Language:	Russian
Published:	Central Research Institute for Epidemiology 2017-08-01
Series:	Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:	immunovac vp-4 vaccine therapy schemes antibacterial immunity dynamics of immunologic parameters
Online Access:	https://microbiol.elpub.ru/jour/article/view/174

Similar Items

Application of bacterial therapeutic vaccine Immunovac-VP4 in the treatment of pollinosis
by: M P Kostinov, et al.
Published: (2018-03-01)

POLYCOMPONENT VACCINE IMMUNOVAC-VP-4 AND IMMUNOTHERAPEUTIC CONCEPT OF ITS USE FOR THE PREVENTION AND TREATMENT OF DISEASES CAUSED BY OPPORTUNISTIC MICROORGANISMS
by: N. B. Egorova, et al.
Published: (2019-08-01)

THE EFFECTIVENESS OF IMMUNOVAC VP-4 FOR IMMUNOLOGICAL PARAMETERS IN FREQUENTLY AND LONG-TERM ILL CHILDREN
by: E. P. Foshina, et al.
Published: (2019-08-01)

MICE SERUM CYTOKINE LEVEL UNDER MUCOSAL IMMUNIZATION WITH OPPORTUNISTIC MICROBIAL ANTIGENS
by: N. K. Akhmatova, et al.
Published: (2012-05-01)

MORPHOFUNCTIONAL PECULIARITIES OF MUCOSAL IMMUNITY DEPENDING ON METHODS OF OPPORTUNISTIC MICROBIAL INTRODUCTION
by: O. V. Lebedinskaya, et al.
Published: (2012-05-01)

EFFECTIVENESS OF APPLICATION OF COMBINED THERAPY OF EARLY ERYTHEMA STAGE OF LYME DISEASE TAKING INTO CONSIDERATION IMMUNOGENESIS FEATURES
by: E. V. Sorokina, et al.
Published: (2016-06-01)

Interferon status in estimating the therapy of bronchial asthma with immunomodulating preparations
by: T. P. Ospelnikova, et al.
Published: (2019-08-01)

POSSIBILITIES OF USE OF IMMUNE MODULATORS IN COMPLEX THERAPY OF COMMUNITY-ACQUIRED PNEUMONIAS
by: E. S. Korovkina, et al.
Published: (2017-08-01)

Frontal VP & VA Shunts Versus post parietal VP &VA Shunts
by: A- Hadi Khalili, et al.
Published: (2005-04-01)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
by: Sun Young Park, et al.
Published: (2022-12-01)

In memory of V.P. Harchenko
Published: (2020-04-01)

V.P. Zinchenko Through the Lens of His Relations (Based on V.P. Zinochenko’s Autobiographical Materials
by: Meshcheryakov B.G.
Published: (2021-11-01)

Comparative analysis of the RVA VP7 and VP4 antigenic epitopes circulating in Iran and the Rotarix and RotaTeq vaccines
by: Tina Fallah, et al.
Published: (2024-07-01)

Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment
by: Ashenafi Kiros Wubshet, et al.
Published: (2024-04-01)

Preliminary Study of Radioiodination of VP2
by: MA Huan, et al.
Published: (2016-05-01)

Construction and efficacy of recombinant Newcastle disease virus co-expressing VP2 and VP3 proteins of very virulent infectious bursal disease virus
by: Tongfei Liu, et al.
Published: (2025-01-01)

Construction of Recombinant Marek’s Disease Virus Co-Expressing VP1 and VP2 of Chicken Infectious Anemia Virus
by: Kai Li, et al.
Published: (2024-09-01)

Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains
by: Tongyao Mao, et al.
Published: (2022-08-01)

Corrigendum: Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains
by: Tongyao Mao, et al.
Published: (2024-08-01)

HSP70 positively regulates translation by interacting with the IRES and stabilizes the viral structural proteins VP1 and VP3 to facilitate duck hepatitis A virus type 1 replication
by: Yurui Jiang, et al.
Published: (2024-05-01)

Molecular Characterization of Outer Capsid Proteins VP5 and VP7 of Grass Carp Reovirus
by: Fuxian Zhang, et al.
Published: (2022-05-01)

V.P. Krymskaya - teacher, scientist, methodologist
Published: (2006-08-01)

Virus-like particles based on rotavarus A recombinant VP2/VP6 proteins for assessment the antibody immune response by ELISA
by: Ilya E. Filatov, et al.
Published: (2023-05-01)

Increased Clinical Signs and Mortality in IFNAR<sup>(−/−)</sup> Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype
by: Houssam Attoui, et al.
Published: (2023-04-01)

A compositional analysis of VP anaphors
by: Gabriel Flambard
Published: (2018-07-01)

VP Shunt Complications: Ten Years Experience at UDMNINAS
by: Subash Lohani, et al.
Published: (2019-12-01)

Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products
by: Muhammad Hayat, et al.
Published: (2024-06-01)

Expresión y purificación de las proteínas estructurales del rotavirus VP5* y VP8* en bacterias E. coli BL21(DE3)
by: Luz Yurany Moreno, et al.
Published: (2013-06-01)

Manajemen Anestesi untuk Tindakan Vp-Shunt pada Bayi Sindrom Crouzon dengan Hidrosefalus
by: Chrismas Gideon Bangun, et al.
Published: (2019-03-01)

Development of a Kit for Rapid Immunochromatographic Detection of Sacbrood Virus Infecting <i>Apis cerana</i> (AcSBV) Based on Polyclonal and Monoclonal Antibodies Raised against Recombinant VP1 and VP2 Expressed in <i>Escherichia coli</i>
by: Song Hee Lee, et al.
Published: (2021-12-01)

In silico Evolutionary Divergence Analysis Suggests the Potentiality of Capsid Protein VP2 in Serotype-Independent Foot-and-Mouth Disease Virus Detection
by: Israt Dilruba Mishu, et al.
Published: (2020-09-01)

Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24
by: Palaniappan Ramanathan, et al.
Published: (2023-04-01)

Migration of Distal End of VP Shunt into the Scrotum: A Management Review
by: Mahmoud M. Taha, et al.
Published: (2022-07-01)

Recombinant Marek’s disease virus expressing VP1 and VP2 proteins provides robust immune protection against chicken infectious anemia virus
by: Chengfei Ge, et al.
Published: (2025-01-01)

Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
by: Vladislav A. Lapin, et al.
Published: (2024-11-01)

Medulloblastoma: seeding of VP shunt tract and peritoneum
by: David Pettersson, et al.
Published: (2012-03-01)

Avaliação do Potencial Cardiotóxico do Vp-16 Através de um Modelo Experimental Utilizando Ratas Albinas: Discussão de Achados Anátomo-Patológicos
by: Gilberto Schvvartsmann, et al.
Published: (2023-08-01)

Characterization of monoclonal antibodies against waterfowl parvoviruses VP3 protein
by: Yin Xiuchen, et al.
Published: (2012-11-01)

Expresión y purificación de las proteínas estructurales del rotavirus VP5* y VP8* en bacterias E. coli BL21(DE3)
by: Luz Yurany Moreno, et al.
Published: (2013-01-01)

Pengaruh Pupuk Hayati VP3 Dengan Persentase Limbah Cangkang Telur Berbeda Terhadap Pertumbuhan Bibit Tanaman Terong (Solanum melongena L.) (Hasil Optimalisasi Suhu Pembuatan Pelet Pupuk Hayati VP3 Berbahan Dasar Limbah Cangkang Telur)
by: Vivin Hafidatur Rofi'ah, et al.
Published: (2023-08-01)